Sign in

Private company

APx Acquisition Corp. I

APx Acquisition Corp. I is a blank check company.1 It is headquartered in Grand Cayman, Cayman Islands.1

Last updated Oct 21, 2026.

Overview

-$119.1KNet income, fiscal 20242
  • IndustryBlank Checks1
  • HeadquartersGrand Cayman, Cayman Islands1
  • Business addressUgland House, Po Box 309, Grand Cayman, E9 Ky1-11043
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3

See how the biggest companies compare on our leaderboards

We will not be limited to a particular industry or geographic region in our identification and acquisition of a target company.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income52-$2.6M in 2024+134% since 2022
-$3.0M-$2.0M-$1.0M02022: -$1.1M-$1.1M20222023: -$1.7M-$1.7M2023+56%2024: -$2.6M-$2.6M2024+50%
Net income52-$119.1K in 2024
-$5.0M0$5.0M$10.0M$15.0M2022: $13.4M$13.4M20222023: $4.3M$4.3M2023−68%2024: -$119.1K-$119.1K2024
Fiscal year2021202220232024
Operating income-$1.1M5-$1.7M2-$2.6M2
Income tax$02
Net income$13.4M5$4.3M2-$119.1K2
Shares (weighted, diluted)17.2M shares917.6M shares5

Compare APx Acquisition Corp. I with another company

Corporate structure

APx Acquisition Corp. I sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of APx Acquisition Corp. I

  • APx Acquisition Corp. I Grand Cayman, Cayman Islands

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What APx Acquisition Corp. I reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Properties, in its own words

We currently maintain our executive offices at 714 Westview Avenue, Nashville, Tennessee 37205. We consider our current office space adequate for our current operations.

Item 2 of the 10-K filed Mar 31, 2025.4

Leadership

Who has led APx Acquisition Corp. I, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Daniel Braatz2021
  2. Kyle P. Bransfield2024

Chief financial officer

  1. Xavier Martinez2021
2025
Board members and other officers (6)

Timeline

  1. Dec 16, 20248-K Listing notice or transfer18
  2. Dec 10, 20248-K Entered a material agreement; Bylaws or fiscal year changed; Shareholder vote19
  3. Nov 8, 20248-K Entered a material agreement; New debt or obligation20
  4. Nov 1, 20248-K Listing notice or transfer21
  5. Sep 9, 20248-K Listing notice or transfer22
  6. Sep 3, 20248-K Ended a material agreement23
  7. Aug 28, 20248-K Entered a material agreement; New debt or obligation24
  8. Jun 5, 20248-K Listing notice or transfer25
  9. May 2, 20248-K Executive or director change26
  10. May 2, 20248-K Executive or director change27
  11. Apr 11, 20248-K Executive or director change28
  12. Mar 29, 20248-K Entered a material agreement29
  13. Feb 8, 2024New chief executive Kyle P. Bransfield becomes CEO11
  14. Dec 6, 2021New chief executive Daniel Braatz becomes CEO12

Filings

128 filings to the SEC since October 2021: 5 annual reports, 11 quarterly reports, 37 major events, 14 insider forms, 25 large holders, 36 other. The latest 20:

  1. Jul 18, 2025F-4/A REGISTRATION STATEMENT EDGAR
  2. Jul 3, 2025F-4/A REGISTRATION STATEMENT EDGAR
  3. Jun 13, 2025F-4/A REGISTRATION STATEMENT EDGAR
  4. Jun 11, 202510-Q QUARTERLY REPORT EDGAR
  5. Mar 31, 2025F-4/A REGISTRATION STATEMENT EDGAR
  6. Mar 31, 202510-K ANNUAL REPORT EDGAR
  7. Feb 14, 2025SCHEDULE 13G/A EDGAR
  8. Feb 11, 2025SCHEDULE 13G/A EDGAR
  9. Jan 22, 2025F-4 REGISTRATION STATEMENT EDGAR
  10. Jan 7, 2025SCHEDULE 13G/A EDGAR
  11. Jan 7, 2025SCHEDULE 13G EDGAR
  12. Dec 16, 20248-K EDGAR
  13. Dec 10, 20248-K CURRENT REPORT EDGAR
  14. Nov 22, 2024DEF 14A EDGAR
  15. Nov 22, 202410-Q EDGAR
  16. Nov 14, 2024SC 13G 13G APXI EDGAR
  17. Nov 14, 2024SC 13G EDGAR
  18. Nov 12, 2024PRE 14A EDGAR
  19. Nov 8, 20248-K EDGAR
  20. Nov 1, 20248-K EDGAR

The 128 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How APx Acquisition Corp. I is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAPx Acquisition Corp. I1
  • CIK0001868573
  • Employer ID (EIN)00-00000004
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inCayman Islands4
  • Fiscal year endsDecember 311
  • Industry code (SIC)6770 Blank Checks1
  • SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
  • Business addressUgland House, Po Box 309, Grand Cayman, E9 KY1-11041
  • Phone1 345 949 80661
  • Shares outstanding4,832,556 Common Class A shares as of Mar 31, 20254
  • Public float$65.0M as of Jun 30, 20244
  • AuditorMarcum LLP, Houston, Texas PCAOB ID 688; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceJul 16, 20211
  • Filings132 in all: 8-K (30), SC 13G (11), 10-Q (10), SC 13G/A (9), 3 (8), 8-K/A (7), 4 (6), CORRESP (5)1
    All 31 form types

    UPLOAD (5), 10-K (4), DEF 14A (4), F-4/A (4), PRE 14A (4), NT 10-Q (3), SCHEDULE 13G/A (3), 25-NSE (2), DEFA14A (2), DRS (2), 10-K/A (1), 10-Q/A (1), 424B4 (1), 425 (1), 8-A12B (1), CERT (1), EFFECT (1), F-4 (1), NT 10-K (1), S-1 (1), SC 13D (1), SC 14F1 (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2025
    Quarterly report (10-Q) Jun 11, 2025
    Proxy statement (DEF 14A) Nov 22, 2024
    Latest 8-K (8-K) Dec 16, 2024

Securities registered for trading

ClassSymbolExchange
Units, each consisting of one Class A Ordinary Share and one-half of one Redeemable WarrantAPXIUThe NASDAQ Stock Market LLC
Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per shareAPXIWThe NASDAQ Stock Market LLC

From the cover page of the 10-K filed Mar 31, 2025 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

The risks APx Acquisition Corp. I names in Item 1A of its 10-K filed Mar 31, 2025: 77 risks under these headings, as written.4

  • For additional risks related to OmnigenicsAI and the Proposed Business Combination, please see the Registration Statement on Form F-4 once filed that is expected to be filed in connection with the Proposed Business Combination.
  • Risks Relating to Our Search for, Consummation of, or Inability to Consummate, a Business Combination and Post-Business Combination Risks
  • We are an early stage incorporated exempted company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective.
  • The Proposed Business Combination is subject to the satisfaction of certain conditions, which may not be satisfied on a timely basis, if at all.
  • Past performance may not be indicative of future performance of an investment in our securities. Further, in the event of the termination of the Proposed Business Combination, we expect that the market price of our securities would immediately and materially decrease, and there can be no assurance that we would be able to identify and consummate an alternative business combination or as to the value of any such alternative business combination to our stockholders.
  • In the event that the Proposed Business Combination were to be terminated, you would be unable to ascertain the merits or risks of any alternative target business prior to our entry into an alternative business combination agreement.
  • Our public shareholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders of our founder shares will participate in such vote, which means we may complete our initial business combination even though a majority of our public shareholders do not support such a combination.
  • Your only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash.
  • Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination within the required time period. If we are unable to complete our initial business combination, our public shareholders may receive only their pro rata portion of the funds in the Trust Account that are available for distribution to public shareholders, and our warrants will expire worthless.
  • The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target.
  • The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure.
  • The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.
The other 65 risks
  • The requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our business combination deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our shareholders.
  • Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by negative impacts on the global economy, capital markets or other geopolitical conditions resulting from the invasion of Ukraine by Russia and Hamas’ attack of Israel and the ensuing war.
  • We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public shareholders may receive only $12.05 per share, or less than such amount in certain circumstances, and our warrants will expire worthless.
  • If we are unable to consummate our initial business combination within the prescribed time frame, our public shareholders may be forced to wait beyond such time frame before redemption from our Trust Account.
  • If we seek shareholder approval of our initial business combination, our initial shareholders and management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
  • If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for submitting or tendering its shares, such shares may not be redeemed.
  • We may be unable to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon a particular business combination.
  • Although we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria and guidelines.
  • We may seek business combination opportunities in industries or sectors that may be outside of our management’s areas of expertise.
  • Resources could be wasted in researching business combinations that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business combination, our public shareholders may only receive their pro rata portion of the funds in the Trust Account that are available for distribution to public shareholders, and our warrants will expire worthless.
  • We may have a limited ability to assess the management of a prospective target business and, as a result, may effect our initial business combination with a target business whose management may not have the skills, qualifications or abilities to manage a public company.
  • We may seek acquisition opportunities with an early-stage company, a financially unstable business or an entity lacking an established record of revenue or earnings.
  • The officers and directors of an acquisition candidate may resign upon completion of our initial business combination. The loss of a business combination target’s key personnel could negatively impact the operations and profitability of our post-combination business.
  • Since our Sponsors, officers and directors will lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after the IPO), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination.
  • The nominal purchase price paid by our Sponsors for the founder shares may significantly dilute the implied value of your public shares in the event we consummate an initial business combination, and our Sponsors are likely to make a substantial profit on its investment in us in the event we consummate an initial business combination, even if the business combination causes the trading price of our ordinary shares to decline materially.
  • Because we must furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective target businesses.
  • Subsequent to our completion of our initial business combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial condition, results of operations and the price of our securities, which could cause you to lose some or all of your investment.
  • If third parties bring claims against us, the funds held in the Trust Account could be reduced and the per-share redemption amount received by shareholders may be less than $12.05 per share.
  • Our directors may decide not to enforce the indemnification obligations of our Sponsors, resulting in a reduction in the amount of funds in the Trust Account available for distribution to our public shareholders.
  • The securities in which we invest the funds held in the Trust Account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $12.05 per share.
  • If, after we distribute the funds in the Trust Account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our board of directors and us to claims of punitive damages.
  • If, before distributing the funds in the Trust Account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with our liquidation may be reduced.
  • Our shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption of their shares.
  • We may not hold an annual general meeting until after the consummation of our initial business combination, which could delay the opportunity for our shareholders to appoint directors.
  • Because we are not limited to evaluating a target business in a particular industry sector, you will be unable to ascertain the merits or risks of any particular target business’s operations.
  • We are not required to obtain an opinion from an independent investment banking firm or from a valuation or appraisal firm, and consequently, you have no assurance from an independent source that the price we are paying for the business is fair to our shareholders from a financial point of view.
  • Unlike most other similarly structured blank check companies, our Sponsors will receive additional founder shares if we issue shares to complete an initial business combination.
  • We issued and may issue additional notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.
  • We may issue our shares to investors in connection with our initial business combination at a price which is less than the prevailing market price of our shares at that time.
  • We may only be able to complete one business combination with the proceeds of the IPO and the sale of the private placement warrants, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability.
  • We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.
  • We may seek business combination opportunities with a high degree of complexity that require significant operational improvements, which could delay or prevent us from achieving our desired results.
  • Our management may not be able to maintain control of a target business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management will possess the skills, qualifications or abilities necessary to profitably operate such business.
  • We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our initial business combination with which a substantial majority of our shareholders do not agree.
  • Certain agreements related to the IPO may be amended without shareholder approval.
  • Our initial shareholders, including our Sponsors, control a substantial interest in us and thus may exert substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support.
  • As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination.
  • Risks Relating to Our Sponsors and Management Team
  • We are dependent upon our officers and directors and their loss could adversely affect our ability to operate.
  • Our ability to successfully effect our initial business combination and to be successful thereafter will be dependent upon the efforts of our key personnel, some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations and profitability of our post-combination business.
  • Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination, and a particular business combination may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous.
  • Our officers and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business combination.
  • Our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
  • Our officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
  • We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our Sponsors, officers, directors, existing holders or funds managed by certain of our affiliates which may raise potential conflicts of interest.
  • Certain members of our board of directors and management team may be involved in and have a greater financial interest in the performance of other entities affiliated with our Sponsors, and such activities may create conflicts of interest in making decisions on our behalf.
  • Risks Relating to Our Securities
  • You will not have any rights or interests in funds from the Trust Account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
  • Holders of our public shares will not be entitled to vote on the appointment of directors prior to our initial business combination.
  • If we seek shareholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares in excess of 15% of our Class A ordinary shares.
  • Our warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.
  • If we are deemed to be an investment company for purposes of the Investment Company Act of 1940, as amended (the “Investment Company Act”), we would be required to institute burdensome compliance requirements and our activities would be severely restricted and, as a result, we may abandon our efforts to consummate an initial business combination and liquidate.
  • If we instruct the trustee to liquidate the securities held in the Trust Account and instead to hold the funds in the Trust Account in cash in order to seek to mitigate the risk that we could be deemed to be an investment company for purposes of the Investment Company Act, we would likely receive minimal interest, if any, on the funds held in the Trust Account, which would reduce the dollar amount the public shareholders would receive upon any redemption or liquidation of the Company.
  • You will not be permitted to exercise your warrants unless we register and qualify the underlying Class A ordinary shares or certain exemptions are available.
  • The grant of registration rights to our initial shareholders and holders of our private placement warrants may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our Class A ordinary shares.
  • We may issue additional Class A ordinary shares or preferred shares to complete our initial business combination or under an employee incentive plan after completion of our initial business combination. We may also issue Class A ordinary shares upon the conversion of the founder shares at a ratio greater than one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained therein. Any such issuances would dilute the interest of our shareholders and likely present other risks.
  • In order to effectuate an initial business combination, special purpose acquisition companies, including us, have, in the recent past, amended various provisions of their charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to amend our Articles or governing instruments in a manner that will make it easier for us to complete our initial business combination that our shareholders may not support.
  • We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 65% of the then outstanding public warrants, or for amendments necessary for the warrants to be classified as equity. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.
  • A provision of our warrant agreement may make it more difficult for us to consummate an initial business combination.
  • Our warrants will be accounted for as a warrant liability and will be recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our Class A ordinary shares or may make it more difficult for us to consummate an initial business combination.
  • We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
  • Our warrants may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.
  • Because each unit contains one-half of one warrant and only a whole warrant may be exercised, the units may be worth less than units of other special purpose acquisition companies.
  • There is currently limited market for our securities, which would adversely affect the liquidity and price of our securities.
  • Provisions in our Articles may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class A ordinary shares and could entrench management.
  • Risks Relating to Acquiring and Operating a Business in Foreign Countries
  • If we effect our initial business combination with a company located outside of the United States, we would be subject to a variety of additional risks that may adversely affect us.
  • If our management following our initial business combination is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar with such laws, which could lead to various regulatory issues.

Legal proceedings

As of December 31, 2024, to the knowledge of our management, there was no material litigation, arbitration or governmental proceeding pending against us or any members of our management team in their capacity as such, and we and the members of our management team have not been subject to any such proceeding.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40